About this policy
The comment period for the DL38168 MolDX: Guardant 360® Plasma-Based Comprehensive Genomic Profiling in Solid Tumors Local Coverage Determination (LCD) began on 4/25/2019 and ended on 6/09/2019. The comments below were received from the provider communities in the MolDX Program. The notice period for L38168 begins on 1/30/2020 and it will become effective on 3/15/2020.
Codes in this policy
Code numbers and each code’s status as the policy records it. CPT code descriptions are left out of this page, as are the passages that cite CPT codes; the official document has them.
Backwork has no codes on record for this policy. Check the source.